Skip to content
Screener

INmune Bio INMB Q1 2026 earnings

Reported May 7, 2026 · After market close

EPS-$0.20Beat by $0.04
Revenue estimate$1.1M
EPS estimate-$0.25

Next report

Oct 29, 2026 (in 2 months)
Revenue estimate$1.9M
EPS estimate-$0.15

FAQ

When did INmune Bio report Q1 2026 earnings?
INmune Bio (INMB) reported Q1 2026 earnings on May 7, 2026 after market close.
What were INmune Bio's Q1 2026 revenue and EPS?
INmune Bio reported eps of $-0.20 for Q1 2026.
Did INmune Bio beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.24 by $0.04.
How did INmune Bio's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 53.5% from $-0.43.
Where can I find INmune Bio's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001213900-26-052231) and the 10-Q periodic report (0001213900-26-053338) directly on SEC EDGAR. The filing index links above go to sec.gov.